Assumptions are being shaken up after the unexpected failure of the ECLIPSE trial to show an advantage for orbital ...

Claire Turner, 43, said she didn't have changed moles or skin lesions — a rarity that occurs in about 3% of melanoma cases ...

Image Credit: Ground Picture / Shutterstock.com A recent study in the journal BMC Medicine examines the effects of a Western ...

The FDA approved Emrosi (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions of ...

Mapping cell types in MS lesions reveals unique tissue niches and interactions, offering insights into the molecular drivers ...

A tightly tied waist cord on a saree underskirt may pose a cancer risk.

The US Food and Drug Administration (FDA) has approved Journey Medical’s Emrosi (minocycline hydrochloride extended release capsules 40mg) to treat inflammatory lesions of rosacea in adults. Affecting ...

Several experts argue that AI-QCA is not a replacement for OCT, but could be valuable in low-resource settings.

Expert answers to patients’ questions were offered as part of the CURE® Educated Patient® Prostate Cancer Summit.

The results in patients with long, complex lesions are better than or equal to those of surgery, but without the ...

While AI-assisted colonoscopies with computer-aided detection are associated with improved adenoma detection rates, they also led to a statistically and clinically significant increase in exams that ...

U.S. FDA approved Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the treatment of inflammatory lesions of rosacea in adults; launch expected in late Q1 or early Q2 of 2025 ...